Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Clinical & Translational Endocrinology|November 1, 2021
COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetesKelly Mason, Sana Hasan, Amy Darukhanavala, et al.Birth Defects Research. Part C, Embryo Today : Reviews|December 30, 2016
Challenges in the diagnosis and management of disorders of sex developmentKatherine Kutney, Laura Konczal, Beth Kaminski, et al.Journal of Clinical & Translational Endocrinology|January 13, 2022
Cystic fibrosis related liver disease and endocrine considerationsJordan S Sherwood, Jagdeesh Ullal, Katherine Kutney, et al.Journal of Clinical & Translational Endocrinology|January 21, 2022
Treatment of cystic fibrosis related bone diseaseJagdeesh Ullal, Katherine Kutney, Kristen M Williams, et al.Pediatric Pulmonology|May 2, 2022
Cystic fibrosis-related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosisAravind Thavamani, Krishna K Umapathi, Katherine Kutney, et al.Journal of Clinical & Translational Endocrinology|September 14, 2023
Reproducibility of in-home CFRD screening using continuous glucose monitoring and mixed meal tolerance testKatherine Kutney, Beth A Kaminski, Terri Casey, et al.Pediatric Pulmonology|January 5, 2024
Impact of elexacaftor/tezacaftor/ivacaftor on lipid and fat-soluble vitamin levels and association with body mass indexTanvi Patel, Kimberly McBennett, Senthilkumar Sankararaman, et al.World Journal of Hepatology|January 23, 2020
Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patientsKatherine Kutney, Shannon B Donnola, Chris A Flask, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 26, 2025
Obstructive sleep apnea, glycemic control, and cardiovascular risk in young adults with youth-onset type 2 diabetes: results from the TODAY studyLorraine E Levitt Katz, Laure K El Ghormli, Kristen J Nadeau, et al.Pediatric Nephrology (Berlin, Germany)|July 11, 2023
Trajectories of eGFR and risk of albuminuria in youth with type 2 diabetes: results from the TODAY cohort studyLaure El Ghormli, Hui Wen, Diane Uschner, et al.Pageof 2